SCHEMBL5154645

SCHEMBL5154645

CCOc1ccc(-c2ccc(OC)c(F)c2)cc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.51
LMNA P02545 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
PTPN11 Q06124 3/20 0.49
CFD P00746 1/20 0.48
MGLL Q99685 6/20 0.47
FFAR1 O14842 1/20 0.47
JAK2 O60674 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PTPN1 P18031 1/20 0.46
PTPN6 P29350 1/20 0.46
TNFRSF1A P19438 1/20 0.46
KDM4E B2RXH2 1/20 0.46
APAF1 O14727 1/20 0.46
RECQL P46063 1/20 0.46
CASP6 P55212 1/20 0.46
CACNA1B Q00975 1/20 0.46
APBA1 Q02410 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4600533 0.90 TSHR (0.50) TSHRLMNAMAPK1HTTRAB9A
SCHEMBL4602660 0.90 TSHR (0.47) TSHRPTPN11CFDJAK2HSD17B10
SCHEMBL4600237 0.88 LMNA (0.60) LMNAMAPK1HTTRAB9ACFD
SCHEMBL4603254 0.87 TSHR (0.59) TSHRMAPK1RAB9APTPN11CFD
SCHEMBL2771810 0.87 CFD (0.61) TSHRLMNAMAPK1PTPN11CFD
SCHEMBL4601086 0.86 PTPN11 (0.56) TSHRPTPN11CFDFFAR1HSD17B10
SCHEMBL4600863 0.84 PTPN11 (0.56) TSHRLMNAPTPN11CFDHSD17B10
SCHEMBL4603132 0.83 NEK2 (0.56) TSHRPTPN11CFDHSD17B10PTPN1
SCHEMBL4600782 0.83 PTPN11 (0.54) TSHRLMNAPTPN11CFDHSD17B10
SCHEMBL21561215 0.82 LMNA (0.60) LMNAMAPK1HTTRAB9ACFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R TSHR 122/4885LMNA 3198/4885MAPK1 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.